📢The ESMO - Eur. Oncology Plenary on the final OS results from the TROPION-Breast01 trial oncodaily.com/url/241850 Barbara Pistilli #Cancer #ClinicalTrial #BCSM #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

📣 ESMO #ClinicalPracticeGuideline eUpdate on #OesophagealCancer: in resectable, locally advanced oesophageal adenocarcinoma or OGJ pre- & post-operative #chemotherapy is associated with improved survival vs #Neoadjuvant #Chemoradiotherapy. 🔗 ow.ly/R37w50UYlE9

📣 Join us for an insightful ESMO Webinar on Advanced Urothelial Cancer! 👩‍⚕️Our expert panel will discuss 1st & 2nd line therapies, toxicity management & more. Live Q&A included. 👉Register now! #UrothelialCancer 🔗ow.ly/Etpg50V07hR

Our new ESMO Guideline on HCC is out!

Our first Living Guideline in melanoma is out

Breaking science to practice

📣#ESMORareCancers25 kicks off in Lugano! Join us as we explore the latest in rare cancer research, therapies and molecular advances. A dynamic platform for oncologists, researchers and advocates alike! Let’s push the boundaries of oncology together. 🔗ow.ly/ikth50VjTG0

💡 Insightful editorial on #ESMODailyReporter by our ESMO - Eur. Oncology Director of Policy Jean-Yves Blay 📈 The results of our survey presented today at #ESMORareCancers2025 illustrate the increasing acceptance of high-quality #RealWorldData to support policy & clinical decision-making 🧵

📣Updated: ESMO Guidelines Slideset: Oncogene-Addicted Metastatic Non-small Cell Lung Cancer v1.2 👉 Find Clinical Practice Guideline recommendations in a condensed format, to include in your presentations. #ESMOGuidelines 🔗ow.ly/sGmE50VnVwU

📣#ESMOAI25: The tools to navigate AI and digital health in oncology. Register today and contribute to the global conversation on responsible AI in cancer care. ⏰ Early registration deadline: 3 September 2025 🔗ow.ly/4rkb50VrkkE

💡 The goal: democratize access to precision medicine by promoting standardized, multidisciplinary, and inclusive MTB models. ESMO continues to lead the way in making precision oncology a reality for every patient, everywhere. #ESMO #MolecularTumourBoards #PersonalizedMedicine

Newly published ESMO recommendations provide roadmap for the implementation of molecular tumour boards in clinical practice. Discover the key focus areas to optimise #PrecisionOncology Read via #ESMODailyReporter: ow.ly/mexL50VvtUM Ben Westphalen Annals of Oncology

Our Express Update of the met Pancreatic cancer guideline!

Three CMOs in Athens - ASCO ESMO - Eur. Oncology EORTC George Pentheroudakis & Vassilis Golfinopoulos

📣ESMO Living Guidelines on Metastatic Breast Cancer: 👉Just updated with the latest recommendations and algorithms in an interactive format. 🔗ow.ly/loX750VBoN6 #ClinicalPracticeGuideline

Αυτά αγαπάμε στη Θεσσαλονίκη😍😍

📣 ESMO Living Guideline on Hepatocellular Carcinoma: 👉 New title with the latest recommendations and algorithms in an interactive format. #ClinicalPracticeGuideline Arndt Vogel 🔗 ow.ly/CHpJ50VHbYg

👉 Eric Van Cutsem, ESMO GI 2025 Scientific Co-Chair, invites you to join global leaders at #ESMOGI25 in Barcelona from 2–5 July 2025. ⏰ Register by 4 June to save your seat! 🔗 ow.ly/Q9YP50VMNww

📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up. 🔗 ow.ly/ShMI50VPh7I #ESMOGuidelines

ESMO with a new Rectal Cancer CPG!